China 99% Tamoxifen

E-mail: [email protected] Skype: ycgc1992 Tamoxifen CAS :54965-24-1 MF: C32H37NO8 MW: 563.64 Assay :99-101% Appearance: white to off-white powder Package: foil bag Uses: For the treatment of advanced, recurrent breast cancer and ovarian cancer and other illnesses. Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. Tamoxifen is currently used for the treatment of both early and advanced ER + (estrogen receptor positive) breast cancer in pre-and post-menopausal women. Additionally, Tamoxifen is the most common hormone treatment for male breast cancer. Tamoxifen is also approved by the FDA for the prevention of breast cancer in women at high risk of developing the disease. Tamoxifen has been further approved for the reduction of contralateral (in the opposite breast) cancer.